Literature DB >> 7986498

Botulinum toxin treatment in patients with hemifacial spasm.

R Laskawi1, M Ellies, C Drobik, A Bätz.   

Abstract

Hemifacial spasm is nearly always a unilateral disease of the facial musculature and is characterized by involuntary tonic or clonic cramps that considerably reduce the affected patient's quality of life. In the past, a number of different conservative and operative therapeutic procedures have been applied for the treatment of hemifacial spasm. In many cases these attempts failed to control the disease permanently or resulted in unwanted, sometimes strong, side effects. We report our own experiences with botulinum therapy in 29 patients with hemifacial spasm (78 therapeutic sessions). In our patients the mean duration of an effect after treatment with botulinum toxin was 18.2 weeks. Side effects were rare. Our results since 1990 at the University of Göttingen demonstrate that subcutaneous application of toxin from Clostridium botulinum to involved facial muscles represents a reliable method for successful treatment of hemifacial spasm.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7986498     DOI: 10.1007/BF00181883

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  18 in total

1.  [Local injection treatment with botulinum toxin A in blepharospasm, Meige syndrome and hemifacial spasm. Observations in 106 patients].

Authors:  A O Ceballos-Baumann; T Gasser; R Dengler; W H Oertel
Journal:  Nervenarzt       Date:  1990-10       Impact factor: 1.214

2.  Etiology and definitive microsurgical treatment of hemifacial spasm. Operative techniques and results in 47 patients.

Authors:  P J Jannetta; M Abbasy; J C Maroon; F M Ramos; M S Albin
Journal:  J Neurosurg       Date:  1977-09       Impact factor: 5.115

3.  The surgical treatment of hemifacial spasm.

Authors:  J GREENWOOD
Journal:  J Neurosurg       Date:  1946-11       Impact factor: 5.115

4.  Botulinum toxin injection therapy for hemifacial spasm.

Authors:  E Tolosa; M J Martí; J Kulisevsky
Journal:  Adv Neurol       Date:  1988

5.  Carbamazepine for hemifacial spasm.

Authors:  G E Alexander; H Moses
Journal:  Neurology       Date:  1982-03       Impact factor: 9.910

Review 6.  Botulinum toxin injection of eye muscles to correct strabismus.

Authors:  A B Scott
Journal:  Trans Am Ophthalmol Soc       Date:  1981

7.  Myectomy for essential blepharospasm.

Authors:  T W Jones; R R Waller; J R Samples
Journal:  Mayo Clin Proc       Date:  1985-10       Impact factor: 7.616

8.  Hemifacial spasm. Comparison of three different operative procedures in 110 patients.

Authors:  T Iwakuma; A Matsumoto; N Nakamura
Journal:  J Neurosurg       Date:  1982-12       Impact factor: 5.115

9.  Treatment of tic douloureux and hemifacial spasm by posterior fossa exploration: therapeutic implications of various neurovascular relationships.

Authors:  J H Piatt; R H Wilkins
Journal:  Neurosurgery       Date:  1984-04       Impact factor: 4.654

10.  Hemifacial spasm treated with botulinum A toxin injection.

Authors:  P J Savino; R C Sergott; T M Bosley; N J Schatz
Journal:  Arch Ophthalmol       Date:  1985-09
View more
  7 in total

Review 1.  [Treatment of laryngeal movement disorders with botulinum toxins: part 1: History and mode of action].

Authors:  C Schwemmle; M Ptok
Journal:  HNO       Date:  2007-05       Impact factor: 1.284

2.  Costs of treating dystonias and hemifacial spasm with botulinum toxin A.

Authors:  R C Dodel; A Kirchner; R Koehne-Volland; G Künig; A Ceballos-Baumann; M Naumann; A Brashear; H P Richter; T D Szucs; W H Oertel
Journal:  Pharmacoeconomics       Date:  1997-12       Impact factor: 4.981

3.  Therapeutic Approach to Botulinum Injections for Hemifacial Spasm, Synkinesis and Blepharospasm.

Authors:  Gilad Yahalom; Amir Janah; Gustavo Rajz; Roni Eichel
Journal:  Toxins (Basel)       Date:  2022-05-23       Impact factor: 5.075

4.  Histopathological and radiological investigations of the influence of botulinum toxin on the submandibular gland of the rat.

Authors:  Berna Uslu Coskun; Hayati Savk; Esin Derin Cicek; Tulay Basak; Muzaffer Basak; Burhan Dadas
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-07       Impact factor: 2.503

Review 5.  [Botulinum toxin in otorhinolaryngology].

Authors:  S Rohrbach; R Laskawi
Journal:  HNO       Date:  2004-07       Impact factor: 1.284

6.  Validation of a new hemifacial spasm grading questionnaire (HFS score) assessing clinical and quality of life parameters.

Authors:  Bettina Wabbels; Ali Yaqubi
Journal:  J Neural Transm (Vienna)       Date:  2021-05-08       Impact factor: 3.575

7.  Surgical and conservative methods for restoring impaired motor function - facial nerve, spinal accessory nerve, hypoglossal nerve (not including vagal nerve or swallowing).

Authors:  R Laskawi; S Rohrbach
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.